Skip to content

Bartels Extracellular Matrix

by Baxter Healthcare Corp

510(k) K902726

Bartels Extracellular Matrix is a Class I device made by Baxter Healthcare Corp, cleared under FDA 510(k) K902726 on 24 Sep 1990, active as of 11 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 11 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 11 Oct 2026.

Regulatory status

as of registry sync 11 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK902726 Date24 Sep 1990ClearedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
KIR
Device class
Class I
Regulation
21 CFR Part 864.2280
Advisory committee
Hematology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code KIR (Cells, Animal And Human, Cultured).

Other devices from Baxter Healthcare Corp

See all devices from Baxter Healthcare Corp →